Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) snapped a three-day winning streak on Thursday, surging as much as 17.9 percent ...

As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a ...

Recursion Pharmaceuticals (RXRX) held about $557 million in cash at the end of its second quarter of 2026. Investors should ...

At the dawn of the era where AI improves AI, I will write about what I, as someone in the field, have been thinking.ELYZA ...

Since I called it three times in the recursion, the return process also happens three times. Even though I understood it in ...

Learn more about whether CareDx, Inc. or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

NAMI crypto presale update has raised $738600 of $2M at 10 USDC. See token rewards, NAMI token airdrop, unlock Schedule dates ...

You don’t need a weatherman to know which way the AI doomsday wind blows.

We introduce Multi-Agent Self-Supervision (MASS). One shared model solves tasks through a team of virtual subagents, searches for better multi-agent workflows, then uses its own judgments to select ...

Anthropic has revealed that its Claude AI models are playing an important role in the development of future AI systems. All you need to know.

AI-detection scores are a black box. But a writing process visualizer lays the groundwork for rich conversations about AI and ...

Recursive self-improvement could allow AI systems to design and build powerful versions of themselves, potentially accelerating progress toward superintelligent AI.